| 货号 | | 品名 | | CAS No. | | 分子式 | | 包装规格 | | 应用 |
| T350050 | | 2-Thio-2’-deoxy Cytidine | | 169557-13-5 | | C9H13N3O3S | | 10/100mg | | 2-含硫吡啶核苷 |
| D230625 | | Delavirdine | | 136817-59-9 | | C22H28N6O3S | | 10/100mg | | BHAP逆转录酶YZ剂 |
| D230630 | | Delavirdine Mesylate | | 147221-93-0 | | C23H32N6O6S2 | | 10/100mg | | BHAP逆转录酶YZ剂 |
| D528800 | | Dolutegravir | | 1051375-16-6 | | C20H19F2N3O5 | | 2.5/25mg | | Dolutegravir分析标准品 |
| I525000 | | Indinavir Sulfate | | 157810-81-6 | | C36H49N5O8S | | 5/50mg | | Hiv -1蛋白酶YZ剂 |
| I525001 | | Indinavir | | 150378-17-9 | | C36H49N5O8S | | 10/100mg | | Hiv - 1蛋白酶YZ剂 |
| N391275 | | Nevirapine | | 129618-40-2 | | C15H14N4O | | 5/50/250mg | | hiv - 1强有力的(IC50 = 84 nm)和选择性非核苷逆转录酶YZ剂 |
| N389750 | | Nelfinavir Mesylate | | 159989-65-8 | | C33H49N3O7S2 | | 10/100mg | | HIV蛋白酶YZ剂 |
| C633150 | | Cobicistat | | 1004316-88-4 | | C40H53N7O5S2 | | 10/25/50mg | | HIV蛋白酶YZ剂 |
| P681025 | | Podorhizol β-D-Glucopyranoside | | 17187-73-4 | | C28H34O13 | | 2.5/25mg | | Podorhizol β-D-吡喃葡萄糖苷,抗病毒剂 |
| A607897 | | (2S,3S,5S)-5-Amino-1,6-diphenyl-2-([[thiazol-5-ylmethoxy)carbonyl]amino]hexan-3-yl 2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoate Hydrochloride-d6 | | | | C37H43D6ClN6O5S2 | | 0.5/5mg | | Ritonavor前体 |
| D201750 | | 3-Deazaneplanocin A | | 120964-45-6 | | C12H15ClN4O3 | | 1/5/10mg | | S-adenosylhomocysteineydrolase水解酶YZ剂 |
| C982175 | | 3-Cyano-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-1,2,4-triazole | | 40371-99-1 | | C14H16N4O7 | | 25/250mg | | Viramidine 衍生物 |
| A105015 | | ent-Abacavir | | 136470-79-6 | | C14H18N6O | | 5/50mg | | 阿巴卡韦对映体,核苷逆转录酶YZ剂 |
| A192450 | | Acyclovir N-Methylene Dimer | | | | C17H22N10O6 | | 1/10mg | | 阿昔洛韦二聚杂质 |
| F696850 | | 4-Formyl Antipyrine | | 950-81-2 | | C12H12N2O2 | | 2.5/25g | | 安替比林衍生物 |
| O239020 | | Octaverine Hydrochloride | | 6775-26-4 | | C23H28ClNO5 | | 10/100mg | | 奥他维林盐酸盐分析标准品 |
| T662400 | | 3’’-O-Tosyl Entecavir | | | | C19H21N5O5S | | 5/50mg | | 保护的恩替卡韦 |
| N389752 | | Nelfinavir-d3 | | | | C32H42D3N3O4S | | 1/10mg | | 标记的HIV蛋白酶YZ剂 |
| L379002 | | Levovirin -13C5 | | | | C313C5H12N4O5 | | 0.5/5mg | | 标记的Levovirin类似物 |
| A634402 | | Amprenavir-d4 | | | | C25H31D4N3O6S | | 1/10mg | | 标记的安普那韦 |
| F696852 | | 4-Formyl Antipyrine-d3 | | | | C12H9D3N2O2 | | 5/50mg | | 标记的安替比林衍生物 |
| G235022 | | Ganciclovir Mono-O-propionate-d5 | | | | C12H12D5N5O5 | | 1/10mg | | 标记的更昔洛韦Mono-O-丙酸酯类似物。是更昔洛韦潜在的前体。抗病毒剂。 |
| M526802 | | 2’-Monodehydroxy-2’-chloro Ganciclovir-d5 | | | | C9H7D5ClN5O3 | | 1/10mg | | 标记的更昔洛韦杂质 |
| B190250 | | Benzethonium Chloride | | 121-54-0 | | C27H42ClNO2 | | 10/100g | | 标记的合成的季铵盐具有表面活性剂、杀菌和抗感染的特性 |
| B190252 | | Benzethonium-d7 Chloride | | | | C27H35D7ClNO2 | | 5/50mg | | 标记的合成的季铵盐具有表面活性剂、杀菌和抗感染的特性 |
| L172502 | | Lamivudine-15N2,13C | | | | C713CH11N15N2O3S | | 1/10mg | | 标记的拉米夫定 |
| E588527 | | 5’-Epi Lamivudine-15N2,13C | | | | C713CH11N15N2O3S | | 0.5/5mg | | 标记的拉米夫定差向异构体 |
| R414477 | | Ribavirin-13C5 | | | | C313C5H12N4O5 | | 1/10mg | | 标记的利巴韦林 |
| D297432 | | Desthiazolylmethyloxycarbonyl Ritonavir-d6 | | | | C32H39D6N5O3S | | 1/10mg | | 标记的利托那韦代谢物 |
| R701692 | | (5R)-Rupintrivir-d3 | | | | C31H36D3FN4O7 | | 0.25/2.5mg | | 标记的芦平曲韦5R-enantiomer |
| N391277 | | Nevirapine-d5 See N391278 | | | | C15H9D5N4O | | 1/10mg | | 标记的奈韦拉平 |
| N391278 | | Nevirapine-d3 | | 1051419-24-9 | | C15H11D3N4O | | 2.5/25mg | | 标记的奈韦拉平 |
| H948627 | | 2-Hydroxy Nevirapine-d3 | | | | C15H11D3N4O2 | | 1/10mg | | 标记的奈韦拉平代谢物 |
| H948632 | | 3-Hydroxy Nevirapine-d3 | | | | C15H11D3N4O2 | | 0.5/5mg | | 标记的奈韦拉平代谢物 |
| P580352 | | Pleconaril-d8 (Major) | | 1346602-36-5 | | C18H10D8F3N3O3 | | 1/10mg | | 标记的普拉康纳利,小核糖核酸病毒复制YZ剂,抗病毒。 |
| S135002 | | Saquinavir-d9 | | 1356355-11-7 | | C38H41D9N6O5 | | 1/10mg | | 标记的沙奎那韦 |
| S135003 | | Saquinavir-d6 | | | | C38H44D6N6O5 | | 10mg | | 标记的沙奎那韦 |
| E425002 | | rac Efavirenz-d4 Also see: E425003 | | | | C14H5D4ClF3NO2 | | 1/10mg | | 标记的依法韦仑 |
| E425003 | | rac Efavirenz-d5 (major) | | | | C14H4D5ClF3NO2 | | 0.5/5mg | | 标记的依法韦仑 |
| D232945 | | 2’-Deoxy-2’-fluoro Cytidine | | 10212-20-1 | | C9H12FN3O4 | | 100mg/1g | | 丙型肝炎次基因组强有力YZ剂 |
| E558900 | | Entecavir | | 142217-69-4 | | C12H15N5O3 | | 10/100mg | | 恩替卡韦 |
| H946555 | | 9-((1S,3R,4S)-4-Hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-2-(2-oxo-2-phenylethyl)-1H-purin-6(9H)-one | | | | C19H19N5O4 | | 5mg | | 恩替卡韦苯甲酰保护衍生物,抗病毒 |
| E558920 | | 1’-epi-Entecavir | | | | C12H15N5O3 | | 10/25mg | | 恩替卡韦差向异构体杂质 |
| E558925 | | 3’-epi-Entecavir | | | | C12H15N5O3 | | 10/25mg | | 恩替卡韦差向异构体杂质 |
| E558930 | | 4’-epi-Entecavir | | 1367369-80-9 | | C12H15N5O3 | | 2.5/25mg | | 恩替卡韦差向异构体杂质 |
| H946560 | | 9-((1S,3R,4S)-4-Hydroxy-3-(((4-methoxyphenyl)diphenylmethoxy)methyl)-2-methylenecyclopentyl)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-1H-purin-6(9H)-one | | | | C52H47N5O5 | | 10/100mg | | 恩替卡韦差向异构体杂质 |
| H946565 | | 9-((1S,3R,4R)-4-Hydroxy-3-(((4-methoxyphenyl)diphenylmethoxy)methyl)-2-methylenecyclopentyl)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-1H-purin-6(9H)-one | | | | C52H47N5O5 | | 2.5/25mg | | 恩替卡韦差向异构体杂质 |
| M266070 | | (1S,2R,4S)-2-(((4-Methoxyphenyl)diphenylmethoxy)methyl)-4-(2-(((4-methoxyphenyl)diphenylmethyl)amino)-6-oxo-1H-purin-9(6H)-yl)-3-methylenecyclopentyl 4-nitrobenzoate | | | | C59H50N6O8 | | 5/50mg | | 恩替卡韦差向异构体杂质 |
| E558905 | | ent-Entecavir | | 188399-46-4 | | C12H15N5O3 | | 1/10mg | | 恩替卡韦对映体杂质 |
| D417552 | | 3’,5’-Di-O-benzyl Entecavir-13C2,15N | | | | C2413C2H27N415NO3 | | 0.5/5mg | | 恩替卡韦对映体中间体 |
| M263075 | | (1R,2R,3R,5R)-5-[(4-Methoxyphenyl)-diphenylmethylamino-6-bezyloxy-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-cyclopentanol | | | | C52H49N5O5 | | 2.5/25mg | | 恩替卡韦对映体中间体 |
| M263080 | | 2-N-[(4-Methoxyphenyl)-diphenylmethyl]-4,6’-O-dibenzyl ent-Entecavir | | 1354695-79-6 | | C53H49N5O4 | | 1/10mg | | 恩替卡韦对映体中间体 |
| D417550 | | 3’,5’-Di-O-benzyl Entecavir | | 142217-81-0 | | C26H27N5O3 | | 25/250mg | | 恩替卡韦对映体中间体 |
| E558935 | | (1R,3R,4R)-Entecavir | | 1367369-76-3 | | C12H15N5O3 | | 10/25/50mg | | 恩替卡韦同分异构体杂质 |
| H939670 | | 8-Hydroxy Entecavir | | | | C12H15N5O4 | | 10/25mg | | 恩替卡韦杂质 |
| D417150 | | 3’,5’-Di-O-benzoyl Fialuridine (1:3 α/β Mixture)(see D417160) | | | | C23H18FIN2O7 | | 25/250mg | | 非阿尿苷中间体 |
| D417160 | | 3’,5’-Di-O-benzoyl Fialuridine | | 97614-45-4 | | C23H18FIN2O7 | | 25/250mg | | 非阿尿苷中间体 |
| C365545 | | 6-Chloro-2-cyclopropyl-4-(trifluoromethyl)-quinoline | | 391860-73-4 | | C13H9ClF3N | | 500mg/5g | | 非核苷hiv - 1逆转录酶YZ剂。 |
| E425000 | | Efavirenz | | 154598-52-4 | | C14H9ClF3NO2 | | 10/100mg | | 非核苷hiv - 1逆转录酶YZ剂。 |
| G235020 | | Ganciclovir Mono-O-propionate | | 194159-18-7 | | C12H17N5O5 | | 50/500mg | | 更昔洛韦Mono-O-丙酸酯类似物。是更昔洛韦潜在的前体。抗病毒剂。 |
| G235030 | | Ganciclovir Triphosphate | | 86761-38-8 | | C9H16N5O13P3 | | 1/10mg | | 更昔洛韦三磷酸盐 |
| M526800 | | 2’-Monodehydroxy-2’-chloro Ganciclovir | | 108436-36-8 | | C9H12ClN5O3 | | 50/500mg | | 更昔洛韦杂质 |
| C379785 | | 9-[[2-chloroprop-2-en-1-yl)oxy]methyl]guanine | | | | C9H10ClN5O2 | | 25/50/100mg | | 更昔洛韦杂质 |
| F335002 | | Fialuridine-15N2,13C | | | | C813CH10FI15N2O5 | | 10/25mg | | 核苷类似物 |
| N389765 | | Nelfinavir Sulfone | | 1041389-29-0 | | C32H45N3O6S | | 10/100mg | | 甲磺酸奈非那韦杂质 |
| N389770 | | Nelfinavir Sulfoxide | | 1041389-28-9 | | C32H45N3O5S | | 10/100mg | | 甲磺酸奈非那韦杂质 |
| P838335 | | 2-Propyltriphenylphosphonium Bromide | | 1530-33-2 | | C21H22BrP | | 100mg/1g | | 具有抗病毒活性 |
| P681000 | | Podophyllotoxin | | 518-28-5 | | C22H22O8 | | 500mg/5g | | 抗HPVs剂 |
| R414475 | | Ribavirin | | 36791-04-5 | | C8H12N4O5 | | 100mg/250mg/1g | | 抗病毒剂 |
| E425010 | | Efavirenz Pen-3-ene-1-yne(cis/trans Mixture) | | | | C14H9ClF3NO2 | | 2.5/25mg | | 抗病毒剂 |
| E555600 | | Enfuvirtide Acetate | | 914454-00-5 | | C206H305N51O66 | | 100mg | | 抗逆转录病物用于ZL艾滋病毒感染 |
| E588525 | | 5’-Epi Lamivudine | | 139757-68-9 | | C8H11N3O3S | | 1/10mg | | 拉米夫定差向异构体标准品 |
| L172510 | | Lamivudine Triphosphate Ammonium Salt | | 1187058-42-9 | | C8H23N6O12P3S | | 1/10mg | | 拉米夫定代谢物 |
| L172515 | | Lamivudine Diphosphate Ammonium Salt | | 1187058-41-8 | | C8H19N5O9P2S | | 10mg | | 拉米夫定代谢物 |
| L172520 | | Lamivudine Monophosphate Ammonium Salt | | 1187058-40-7 | | C8H15N4O6PS | | 1/10mg | | 拉米夫定代谢物 |
| L172500 | | Lamivudine | | 134678-17-4 | | C8H11N3O3S | | 25mg/250mg/1g | | 拉米夫定分析标准品 |
| V673002 | | Viramidine-13C5 Hydrochloride | | | | C313C5H14ClN5O4 | | 5/25mg | | 利巴韦林的前体药物3-甲脒 |
| V673000 | | Viramidine Hydrochloride | | 40372-00-7 | | C8H14ClN5O4 | | 5/50mg | | 利巴韦林的前体药物3-甲脒,抗病毒剂 |
| L379000 | | Levovirin | | 206269-27-4 | | C8H12N4O5 | | 10/100mg | | 利巴韦林对映异构体 |
| 414485 | | Ribavirin Carboxylic Acid | | 39925-19-4 | | C8H11N3O6 | | 10/100mg | | 利巴韦林杂质A |
| B209580 | | 5’-O-Benzoyl Ribavirin | | 58151-90-9 | | C15H16N4O6 | | 5/50mg | | 利巴韦林杂质E |
| A187715 | | 5’-O-Acetyl Ribavirin | | 58151-87-4 | | C10H14N4O6 | | 5/50mg | | 利巴韦林杂质F |
| D297405 | | Des(3-pyridylmethyl tert-Butylaminocarbonyl) Indinavir Hydrochloride | | | | C25H34ClN3O3 | | 10/100mg | | 利托那韦标记代谢物 |
| D297430 | | Desthiazolylmethyloxycarbonyl Ritonavir | | 176655-55-3 | | C32H45N5O3S | | 5/50mg | | 利托那韦类似物 |
| D297450 | | Desthiazolylmethyl Ritonavir | | 256328-82-2 | | C33H43N5O4S | | 5/50mg | | 利托那韦类似物 |
| M325963 | | N-Methyl Ritonavir Bicarbonate | | | | C39H52N6O8S2 | | 5/50mg | | 利托那韦类似物 |
| A607895 | | (2S,3S,5S)-5-Amino-1,6-diphenyl-2-([[thiazol-5-ylmethoxy)carbonyl]amino]hexan-3-yl 2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoate Hydrochloride | | | | C37H49ClN6O5S2 | | 50/500mg | | 利托那韦前体 |
| A634400 | | Amprenavir | | 161814-49-9 | | C25H35N3O6S | | 2.5/25mg | | 利托那韦前体 |
| D230645 | | 4-Dehydroxy-5-hydroxy Ritonavir | | 202816-62-4 | | C37H48N6O5S2 | | 25/250mg | | 利托那韦杂质 |
| D290245 | | 2-Desisopropyl-2-ethyl Ritonavir | | 165315-26-4 | | C36H46N6O5S2 | | 5/50mg | | 利托那韦杂质 |
| T344290 | | 1,3-Thiazol-5-ylmethyl N-[(1S,2S,4S)-4-(acetylamino)-1-benzyl-2-hydroxy-5-phenylpentyl]carbamate | | 1010808-43-1 | | C25H29N3O4S | | 5/50mg | | 利托那韦杂质 |
| A634255 | | Amphotericin B Methyl Ester 90% | | 36148-89-7 | | C48H75NO17 | | 100mg/1g | | 两性霉素B甲基酯是多烯类抗生素两性霉素B衍生物 |
| Z148002 | | Zanamivir-13C,15N2 | | | | C1113CH20N215N2O7 | | 1/5mg | | 流感病毒神经氨酸酶YZ剂 |
| Z148000 | | Zanamivir | | 139110-80-8 | | C12H20N4O7 | | 1/10mg | | 流感病毒神经氨酸酶YZ剂 |
| R701690 | | (5R)-Rupintrivir | | | | C31H39FN4O7 | | 0.25/2.5mg | | 芦平曲韦 5R-enantiomer |
| D476505 | | (αS)-3-[2-(2,6-Dimethylphenoxy)acetyl]-N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide | | 943250-66-6 | | C47H58N4O7 | | 10/100mg | | 洛匹那韦杂质 |
| L469495 | | Lopinavir EP-T Impurity | | | | C57H66N4O7 | | 10/100mg | | 洛匹那韦杂质 |
| X750600 | | (2,6-Xylyloxy)acetyl Lopinavir | | 943250-65-5 | | C47H58N4O7 | | 10/100mg | | 洛匹那韦杂质 |
| G188900 | | Gallic Acid Monohydrate | | 5995-86-8 | | C7H8O6 | | 10/100g | | 没食子酸一水化合物 |
| N888500 | | Novobiocin Sodium Salt | | 1476-53-5 | | C31H35N2NaO11 | | 100mg/1g | | 酶YZ剂;新生霉素用于生产超螺旋质粒DNA。 |
| B399690 | | BIRG 616 BS | | 287980-84-1 | | C12H10N4O | | 10/100mg | | 奈韦拉平代谢物 |
| H948625 | | 2-Hydroxy Nevirapine | | 254889-31-1 | | C15H14N4O2 | | 2.5/25mg | | 奈韦拉平代谢物 |
| H948630 | | 3-Hydroxy Nevirapine | | 174532-82-2 | | C15H14N4O2 | | 0.5/1/10mg | | 奈韦拉平代谢物 |
| N389760 | | Nelfinavir Hydroxy-tert-butylamide | | 213135-56-9 | | C32H45N3O5S | | 1/10mg | | 奈韦拉平代谢物 |
| S135000 | | Saquinavir Mesylate | | 149845-06-7 | | C39H54N6O8S | | 10/100mg | | 奈韦拉平代谢物,潜在和选择性非核苷hiv - 1逆转录酶YZ剂。 |
| F700830 | | 3-Formyl Nevirapine | | 174532-77-5 | | C16H14N4O2 | | 1/10mg | | 奈韦拉平代谢物中间体 |
| B682770 | | N-[5-Bromo-2-(cyclopropylamino)-4-methyl-3-pyridinyl]-2-chloro-3-pyridinecarboxamide | | 284686-20-0 | | C15H14BrClN4O | | 5/50mg | | 奈韦拉平代谢物中间体 |
| B685985 | | 3-Bromo Nevirapine | | 284686-21-1 | | C15H13BrN4O | | 2.5/25mg | | 奈韦拉平代谢物中间体 |
| E678300 | | 3-Ethenyl Nevirapine | | 284686-22-2 | | C17H16N4O | | 1/10mg | | 奈韦拉平代谢物中间体 |
| N391290 | | Nevirapine Dimer | | 1391054-30-0 | | C30H26N8O2 | | 1/10/25mg | | 奈韦拉平二聚体杂质 |
| B399680 | | BIRG 613 BS | | 287980-58-2 | | C15H16N4O | | 10/100mg | | 奈韦拉平衍生物 |
| A170440 | | N-Acetyl O-Benzyl Lamivudine | | 1091585-30-6 | | C17H17N3O5S | | 5/50mg | | 耐药的拉米夫定,核苷逆转录酶YZ剂 |
| A170430 | | N-Acetyl O-Benzyl 5’-Epi Lamivudine | | | | C17H17N3O5S | | 2.5/25mg | | 耐药的拉米夫定差向异构体 |
| D474982 | | 3,5-Dimethyl-4-[3-(3-methyl-5-isoxazolyl)propoxy]-benzonitrile-d8 | | | | C16H10D8N2O2 | | 5/50mg | | 普拉康纳利-d8中检体 |
| D474980 | | 3,5-Dimethyl-4-[3-(3-methyl-5-isoxazolyl)propoxy]-benzonitrile | | 130226-18-5 | | C16H18N2O, , , 2 | | 25/250mg | | 普拉康纳利中间体 |
| T774245 | | Triciribine | | 35943-35-2 | | C13H16N6O4 | | 10/100mg | | 曲西立滨分析标准品 |
| R701702 | | Rupintrivir-d4 | | | | C31H35D4FN4O7 | | 0.25/2.5mg | | 人类鼻病毒(HRV)3 c蛋白酶不可逆YZ剂 |
| R701700 | | Rupintrivir | | 223537-30-2 | | C31H39FN4O7 | | 0.25/2.5mg | | 人类鼻病毒(HRV)3 c蛋白酶不可逆YZ剂 |
| S135015 | | Saquinavir Hydroxy-tert-butylamide | | 438200-34-1 | | C38H50N6O6 | | 1/10mg | | 沙奎那韦杂质 |
| R414515 | | Ribavirin 2,3,5-Tri-O-acetyl | | | | C14H18N4O8 | | 50/500mg | | 受保护的利巴韦林,用于抗病毒剂 |
| T016000 | | Telbivudine | | 3424-98-4 | | C10H14N2O5 | | 10/100mg | | 替比夫定,抗病毒剂 |
| T018510 | | Tenofovir Phosphate, >60% (mixture of diastereomers) | | 206646-04-0 | | C9H15N5O7P2 | | 1/10mg | | 替诺福韦代谢物 |
| T018525 | | Tenofovir Diphosphate Triethylamine Salt (mixture of diastereomers) | | | | C9H16N5O10P3•x(C6H15N) | | 1/10mg | | 替诺福韦代谢物 |
| T018520 | | Tenofovir Disoproxil Isopropoxycarbonyl | | 1244022-54-5 | | C23H36N5O12P | | 1/10mg | | 替诺福韦酯衍生物 |
| D528802 | | Dolutegravir-d4 | | | | C20H15D4F2N3O5 | | 10/25/50mg | | 同位素标记Dolutegravir |
| C633152 | | Cobicistat-d8 | | | | C40H46D8N7O5S2 | | 10/25/50mg | | 同位素标记的Cobicistat 类似物 |
| B399682 | | BIRG 613 BS-d7 | | | | C15H9D7N4O | | 2.5/25mg | | 同位素标记的奈韦拉平衍生物 |
| T412002 | | Thymidine-d3 | | 74848-84-3 | | C10H11D3N2O5 | | 2.5/25mg | | 脱氧核糖核酸的组成部分 |
| T412000 | | Thymidine | | 50-89-5 | | C10H14N2O5 | | 25/250g | | 脱氧核糖核酸的组成成分 |
| P580350 | | Pleconaril | | 153168-05-9 | | C18H18F3N3O3 | | 10/50/100mg | | 小核糖核酸病毒复制YZ剂。抗病毒。 |
| R517000 | | Rimantadine Hydrochloride | | 1501-84-4 | | C12H22ClN | | 10/100mg | | 选择性HIV蛋白酶YZ剂 |
| R535000 | | Ritonavir | | 155213-67-5 | | C37H48N6O5S2 | | 10/50mg | | 选择性HIV蛋白酶YZ剂 |
| L469480 | | Lopinavir | | 192725-17-0 | | C37H48N4O5 | | 10/100mg | | 选择性HIV蛋白酶YZ剂,利托那韦类似物,抗病毒剂。 |
| F334990 | | 2’-epi-Fialuridine | | 55612-21-0 | | C9H10FIN2O5 | | 50/100mg | | 一种抗病毒剂,核苷类似物 |
| F335000 | | Fialuridine | | 69123-98-4 | | C9H10FIN2O5 | | 10/100mg | | 一种抗病毒剂,核苷类似物 |
| H941820 | | rac 7-Hydroxy Efavirenz | | 205754-50-3 | | C14H9ClF3NO3 | | 1/10mg | | 依法韦仑代谢物 |
| H941815 | | ent-8-Hydroxy Efavirenz | | 342621-26-5 | | C14H9ClF3NO3 | | 25/50/100mg | | 依法韦仑代谢物 |
| H941825 | | rac 8-Hydroxy Efavirenz | | 205754-32-1 | | C14H9ClF3NO3 | | 1/10mg | | 依法韦仑代谢物 |
| H941830 | | 8-Hydroxy Efavirenz | | 205754-33-2 | | C14H9ClF3NO3 | | 25/50/100mg | | 依法韦仑代谢物 |
| E425005 | | ent-Efavirenz | | 154801-74-8 | | C14H9ClF3NO2 | | 2.5/25mg | | 依法韦仑类似物,核苷hiv - 1逆转录酶YZ剂 |
| B433680 | | Bis(ethoxycarbonyl) Efavirenz Amino Alcohol | | | | C19H19ClF3NO5 | | 10/100mg | | 依法韦仑杂质 |
| C988365 | | 11-cyclopropyl-5,11-dihydro-4-(hydroxymethyl)-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one | | 133627-24-4 | | C15H14N4O3 | | 10/100mg | | 茚地那韦类似物 |
| Z148005 | | Zanamivir Amine | | 130525-62-1 | | C11H18N2O7 | | 1/10mg | | 扎那米韦合成前体 |
| D449365 | | (3aR,4R,7aR)-3a,7a-Dihydro-2-methyl-4-[(1S,2R)-1,2,3-tris(acetyloxy)propyl]-4H-pyrano[3,4-d]oxazole-6-carboxylic Acid Methyl Ester | | 78850-37-0 | | C18H23NO10 | | 50/500mg | | 扎那米韦衍生物制备中间体 |
| Z148030 | | Zanamivir Azide Methyl Ester | | 152178-79-5 | | C12H18N4O7 | | 2.5/25mg | | 扎那米韦衍生物制备中间体 |
| Z148040 | | Zanamivir Azide Triacetate Methyl Ester | | 130525-58-5 | | C18H24N4O10 | | 100mg/1g | | 扎那米韦衍生物制备中间体 |
| D249500 | | 4-Deoxypodophyllotoxin | | 19186-35-7 | | C22H22O7 | | 100mg/1g | | 中草药产品,抗肿瘤、抗病毒和KY |
| P681010 | | Podophyllotoxin 4-O-Glucoside | | 16481-54-2 | | C28H32O13 | | 25/250mg | | 足叶草毒素4 -O葡萄糖苷,抗病毒剂 |
| C365445 | | 2-Chloro-4,6-dimethylpyrimidine | | 4472-44-0 | | C6H7ClN2 | | 2.5/25g | | |